Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents.
about
Design of a Carbonic Anhydrase IX Active-Site Mimic To Screen Inhibitors for Possible Anticancer Properties † ‡Complexes possessing rare "tertiary" sulfonamide nitrogen-to-metal bonds of normal length: fac-[Re(CO)3(N(SO2R)dien)]PF6 complexes with hydrophilic sulfonamide ligands.N-substituted glutamyl sulfonamides as inhibitors of glutamate carboxypeptidase II (GCP2).Orthanilic acid-promoted reverse turn formation in peptides.3-Hy-droxy-2-(4-meth-oxy-benzene-sulfonamido)-butanoic acid.Anti-tumoral effects of a trypsin inhibitor derived from buckwheat in vitro and in vivo.4-(3-Methyl-benzene-sulfonamido)-phenyl 3-methyl-benzene-sulfonateTargeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old IdeasAscaris lumbricoides β carbonic anhydrase: a potential target enzyme for treatment of ascariasis.4-(4-Fluoro-benzene-sulfonamido)-phenyl 4-fluoro-benzene-sulfonate.Death inducing and cytoprotective autophagy in T-47D cells by two common antibacterial drugs: sulphathiazole and sulphacetamideStable overexpression of DNA fragmentation factor in T-47D cells: sensitization of breast cancer cells to apoptosis in response to acetazolamide and sulfabenzamide.Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors.Bacterial, fungal and protozoan carbonic anhydrases as drug targets.Acetazolamide triggers death inducing autophagy in T-47D breast cancer cells.Synthesis and Cytotoxic Evaluation of Some Novel SulfonamideDerivativesAgainst a Few Human Cancer Cells.Facile synthesis of benzothiadiazine 1,1-dioxides, a precursor of RSV inhibitors, by tandem amidation/intramolecular aza-Wittig reactionMajor contribution of the type II beta carbonic anhydrase CanB (Cj0237) to the capnophilic growth phenotype of Campylobacter jejuni.Mechanistic Study of a Photocatalyzed C-S Bond Formation Involving Alkyl/Aryl Thiosulfate.Carbonic anhydrase enzyme as a potential therapeutic target for experimental trichinellosis.Alkylation of Sulfonamides with Trichloroacetimidates under Thermal ConditionsNovel bis-(arylsulfonamide) hydroxamate-based selective MMP inhibitors(4S)-4-Benzyl-N-{[(4S)-4-benzyl-2-oxo-1,3-oxazolidin-3-yl]sulfon-yl}-2-oxo-1,3-oxazolidine-3-carboxamide.4-[2-(1-Acetyl-2-oxopropyl-idene)-hydrazino]-N-(pyrimidin-2-yl)benzene-sulfonamide.Marine Sponge/CuO Nanocrystal: A Natural and Efficient Catalyst for Sulfonamides Synthesis.N-(1-Allyl-1H-indazol-5-yl)-4-meth-oxy-benzene-sulfonamide hemihydrate.Ethyl 3-oxo-2-[(4-sulfamoylphen-yl)hydra-zono]butyrate.Synthesis and Anticancer Activity Assay of Novel Chalcone-Sulfonamide Derivatives.Binding affinities for sulfonamide inhibitors with matrix metalloproteinase-2 using a linear response method.The sulfamide motif in the design of enzyme inhibitors.Secreted neutral metalloproteases of Bacillus anthracis as candidate pathogenic factors.Synthesis, characterization and biological studies of sulfonamide Schiff's bases and some of their metal derivatives.Synthesis, molecular docking, and biological evaluation of some novel hydrazones and pyrazole derivatives as anti-inflammatory agents.Biochemical characterization of the γ-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis, PgiCA.Carbonic anhydrase II in the developing and adult human brain.Solvatochromic and fluorescence behavior of sulfisoxazole.Metal-free I2O5-mediated direct construction of sulfonamides from thiols and amines.Iodine-catalyzed expeditious synthesis of sulfonamides from sulfonyl hydrazides and amines.Identification and Characterization of a Trypsin Inhibitor from Fagopyrum tataricum Seeds.Sulfonamide-Linked Ciprofloxacin, Sulfadiazine and Amantadine Derivatives as a Novel Class of Inhibitors of Jack Bean Urease; Synthesis, Kinetic Mechanism and Molecular Docking.
P2860
Q27653519-4944F3CE-67BF-489D-9B1A-A07D8ECC1D92Q30728428-F7817ABF-DEB8-46DE-99A3-37B86ADF0D72Q33789515-CB9239FA-E20B-4279-9D5C-50C1251C42C2Q34326814-B3E543F3-3D76-474B-B905-B7960BD7B3ACQ35616469-1A10AB0C-2899-4AA8-9B81-D5CB7229B9BEQ35728911-77417496-FD5D-4C70-B917-3265F68A367AQ35743559-E03B0569-6D98-4C7B-94DB-6B82462747F8Q35760031-EA77A90E-4B6E-4482-A9E3-E5C757F7A701Q35781047-A05D37CF-66D9-488F-8993-D5A3D440F4DBQ35933385-C53838B6-5CDD-4719-BC51-DA9637E413AFQ37281885-6E0F917C-919C-4DCF-9CA3-F857B8198880Q37554712-777CA889-5084-45DF-B26A-B8203F25E952Q38102757-540568DE-F600-41C3-9974-77E16C2B6B35Q38559435-CF5AFA95-8542-4EBE-933B-8DF2CC29536AQ39071997-CC329BC1-C1BE-426F-879E-F4BA80FA358AQ39466742-EB71E1D4-3514-480B-83FB-14BC2CC346AEQ39912106-52D658B0-A14B-4E7A-8991-662C0D6E2EA9Q40427632-F58B5F51-CE7C-47AE-AAEF-FE501CEF1A8CQ40504049-14D24384-A613-4A69-8CE2-1AC81CC56DB6Q40754487-90500B12-3F1D-4186-9522-FE51621563FAQ41009551-8CC5CA39-4B57-4483-A2FF-F320076E6D78Q41175771-B1244CFA-371A-4106-9CE2-8839F609DA16Q41351841-2F9BFA95-18A3-4252-8F98-9FA4D7A58E89Q41906258-2634ED4D-6691-4656-9C39-C78AE245304CQ41996912-71E8EF58-A7FE-4F7A-8E03-61ADB47B582BQ42089245-38455BC9-447E-4E35-97E8-0614206D36F5Q42122925-612ECCF7-3DF9-49B2-8503-B89691790447Q42360549-9A494B6F-0E8A-4C0D-BAB1-15EEDEF8B411Q42642728-855E5E66-F734-4BE5-B735-FA8A239B776EQ43168863-ACF18966-37B1-47A0-8D55-763F7C387039Q44922742-DB628C2A-A179-47BB-89F0-1D5D5CB9C3A7Q45329952-46AFF3CD-8ABE-41D0-9E29-64EEBD03E80DQ46192036-3565AB13-AB12-4CF5-99B2-312463310DE9Q47860232-75FDB3E3-AB9F-43ED-AA56-13DE195BE4CBQ48476955-E5E27F13-EDF4-4298-8709-CFCBA91F1AC4Q50550646-40E75628-33BF-4D02-8BB2-1E90B4726A99Q50867530-426A41BC-B67D-49A1-99B2-E462B5D9D7FCQ50916531-2564DF27-2CFF-4114-B7BD-700EACBFC4E2Q51572055-2093E8C4-88EF-4097-A42F-5C0AA7074091Q53099814-E51D7B7C-DE08-4D56-874B-CA4E82F5E527
P2860
Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Protease inhibitors of the sul ...... mmatory, and antiviral agents.
@ast
Protease inhibitors of the sul ...... mmatory, and antiviral agents.
@en
type
label
Protease inhibitors of the sul ...... mmatory, and antiviral agents.
@ast
Protease inhibitors of the sul ...... mmatory, and antiviral agents.
@en
prefLabel
Protease inhibitors of the sul ...... mmatory, and antiviral agents.
@ast
Protease inhibitors of the sul ...... mmatory, and antiviral agents.
@en
P356
P1476
Protease inhibitors of the sul ...... mmatory, and antiviral agents.
@en
P2093
Claudiu T Supuran
P2860
P304
P356
10.1002/MED.10047
P577
2003-09-01T00:00:00Z